ACM
BIIB icon

Ativo Capital Management’s Biogen BIIB Stock Holding History

Ativo Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-845
Closed -$240K – 125
2020
Q3 		$240K Hold
845
– – 0.12% 112
2020
Q2 		$226K Sell
845
-10
-1% -$3.01K 0.12% 101
2020
Q1 		$270K Buy
+855
New +$259K 0.17% 98
2019
Q2 		– Sell
-6,042
Closed -$1.43M – 108
2019
Q1 		$1.43M Buy
6,042
+2,582
+75% +$813K 0.6% 51
2018
Q4 		$1.04M Hold
3,460
– – 0.49% 86
2018
Q3 		$1.22M Buy
+3,460
New +$1.19M 0.33% 118

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ativo Capital Management's BIIB Position: Q4 2020 in Review

Ativo Capital Management sold out of Biogen (BIIB) in Q4 2020, closing a stake of 845 shares — an estimated $240K sold.

Ativo Capital Management first reported a position in BIIB in Q3 2018 and held it in 6 quarters. The position peaked at $1.43M in Q1 2019. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Ativo Capital Management reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Ativo Capital Management sold 845 Biogen shares in Q4 2020, an estimated $240K.
  • Ativo Capital Management first reported a position in Biogen in Q3 2018 and held it in 6 quarters.
  • Ativo Capital Management's Biogen position peaked at $1.43M in Q1 2019.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Ativo Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.